Bristol-Myers Squibb
RELATED ARTICLES
Researcher Profile: Alice Walsh
Alice from Bristol-Myers Squibb shares how she uses data to better inform how we study disease and improve patient care.
Living With Limits Does Not Mean Living Without Hope
For Mitra, living with lupus symptoms and limitations doesn’t mean living without hope.
Researcher Profile: Dr. Ryan Moslin
Researchers like Ryan at Bristol-Myers Squibb are making strides in lupus treatment that were impossible 10 years ago.
Fighting Cancer at the Personal Level
Cancer takes 600,000 lives annually in the U.S., but advanced immuno-oncology treatments are making huge differences.
Researcher Profile: Nils Lonberg
In his role as senior vice president of oncology biology discovery at Bristol-Myers Squibb, Dr. Lonberg leads a drug discovery group responsible for identifying potential immuno-oncology (I-O) treatments.
Translating Science into Valuable Insights to Develop the Next Generation of Personalized Medicines
Each person’s genetic makeup is unique, and the thousands of treatments and medicines currently available to patients vary in how they impact different subsets of the population.
Researcher Profile: Tim Reilly
As vice president of oncology early asset development at Bristol-Myers Squibb (BMS), Dr. Tim Reilly leads a team of researchers who are pursuing the next generation of medicines to fight cancer.
Do Tumors Hold the Key to Their Own Destruction?
By studying the interactions between a tumor and a patient's immune system, researchers at biopharmaceutical companies such as Bristol-Myers Squibb (BMS) are trying to reduce the ambiguity involved in fighting cancer.
How California's Bay Area Biotech Is Advancing Human Health
Nowhere is the partnership between technology and medicine evolving so strongly and quickly than the Bay Area of California.
Targeting the Immune System, Not the Tumor
Immuno-oncology is based on the concept of harnessing the body's own immune system to fight cancer, and recent scientific discoveries and clinical advances have ushered in a truly historical time in cancer research.
POPULAR ARTICLES
HIV/AIDS: From An Acute Fatal Disease to A Chronic, Manageable Condition
<p>The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.</p>
READ MORE
Combatting Sickle Cell Disease with Cell & Gene Therapy
<p><span><span><span><a><span lang="EN"><span>America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.</span></span></a></span></span></span></p>
READ MORE
Why Has Research into Alzheimer's Disease Been So Hard?
<p>Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?</p>
READ MORE
5 Recent Developments Advancing Vaccines
As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.
READ MORE
The Innovation Ecosystem Fuels Breakthroughs
Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.
READ MORE
Understanding mRNA Vaccines
Scientists at Pfizer are breaking barriers with mRNA technology, one of the approaches used to develop COVID-19 vaccines.
READ MORE
Protecting Alzheimer's Research
15 million people will live with Alzheimer's by 2060. We're working to change that.
READ MORE